You are here

Disease

Ebola: Official MSF Response to WHO Declaring Epidemic an "Extraordinary Event"

           

msf.org.uk - August 8, 2014

In a statement released today, the World Health Organization (WHO) declared that West Africa's Ebola epidemic is an "extraordinary event" and now constitutes an international health risk.

"A coordinated international response is deemed essential to stop and reverse the international spread of Ebola," the WHO said in a statement after a two-day meeting of its emergency committee on Ebola.

MSF reaction to WHO Ebola statement

In response, Dr Bart Janssens, Médecins Sans Frontières/Doctors Without Borders (MSF) Director of Operations said:

“Declaring Ebola an international public health emergency shows how seriously WHO is taking the current outbreak but statements won’t save lives

“Now we need this statement to translate into immediate action on the ground. For weeks, MSF has been repeating that a massive medical, epidemiological and public health response is desperately needed to saves lives and reverse the course of the epidemic.

“Lives are being lost because the response is too slow.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola outbreak - map of affected areas

Ebola outbreak map, chart

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO declares Ebola outbreak an international public health emergency

The World Health Organization has declared the Ebola outbreak in West Africa to be an international public health emergency that requires an extraordinary response to stop its spread.

It is the largest and longest outbreak ever recorded of Ebola, which has a death rate of about 50 per cent and has so far killed at least 932 people.

"Countries affected to date simply do not have the capacity to manage an outbreak of this size and complexity on their own," WHO chief, Dr. Margaret Chan, said at a news conference in Geneva. "I urge the international community to provide this support on the most urgent basis possible."

"Statements won't save lives," said Dr. Bart Janssens, director of operations for Doctors Without Borders. "For weeks, (we) have been repeating that a massive medical, epidemiological and public health response is desperately needed ... Lives are being lost because the response is too slow."

In the United States, the Centers for Disease Control and Prevention have already elevated their Ebola response to the highest level and have recommended against travelling to West Africa. On Thursday, CDC director Dr. Tom Frieden told a Congressional hearing that the current outbreak is set to sicken more people than all previous outbreaks of the disease combined.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO - List of Members of, and Advisers to, the International Health Regulations (2005) Emergency Committee Regarding Ebola

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

who.int - 6 and 7 August 2014

CHAIR

Dr Sam Zaramba

Senior Consultant Surgeon, Former Director General of Health Services, Ministry of Health, Kampala, Uganda

VICE-CHAIR

Professor Robert Steffen

Department of Epidemiology and Prevention of Infectious Diseases, WHO Collaborating Centre for Travellers’ Health, University of Zurich, Zurich, Switzerland

CSPAN - House Foreign Affairs Subcommittee - Ebola Virus

c-span.org - August 7, 2014

The House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations held a hearing titled, “Combating the Ebola Threat.”

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

ZMapp - Information Sheet

                                                        

ZMapp TM is the result of a collaboration between Mapp Biopharmaceutical Inc. and LeafBio (San Diego, CA), Defyrus Inc. (Toronto, Canada), the U.S. government and the Public Health Agency of Canada (PHAC).

ZMapp TM is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana.  It is an optimized cocktail combining the best components of MB-­‐003 (Mapp) and ZMAb (Defyrus/PHAC).

ZMapp TM was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans.  As such very little of the drug is currently available.  

Any decision to use an experimental drug in a patient would be a decision made by the treating physician under the regulatory guidelines of the FDA.

Mapp and its partners are cooperating with appropriate government agencies to increase production as quickly as possible.

CLICK HERE - ZMapp - Information Sheet (1 page .PDF file)

http://www.mappbio.com/

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Experimental Ebola Serum Grown in Tobacco Leaves

                                                     

webmd.com - by Brenda Goodman - reviewed by Michael W. Smith, MD

Aug. 4, 2014 -- ZMapp, the experimental treatment rushed to two Americans infected with Ebola in Africa, is grown in specially modified leaves of tobacco -- a plant better known for harming health than healing.

“We complied with a request from Emory University and Samaritan’s Purse to provide a very limited amount of ZMapp last week,” says David Howard, a spokesman for Reynolds American Services, the parent company of Kentucky BioProcessing. The small biopharma company in Owensboro, KY, has been contracted to grow the drug.

(READ COMPLETE ARTICLE)

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Q & A - What You Need to Know About the Ebola Outbreak

Where is the Outbreak?

      

Source: United Nations Office for the Coordination of Humanitarian Affairs

nytimes.com - by Joe Burgess, Denise Grady, Josh Keller, Heather Murphy and Sergio Peçanha - August 6, 2014

What are the chances of getting Ebola in the United States?

Two American aid workers infected with the Ebola virus while working in West Africa are being treated at a hospital in Atlanta, in a containment unit for patients with dangerous infectious diseases. But the risk that anyone will contract Ebola in the United States is extremely small, experts say.

Doctors across the country are being reminded to ask for the travel history of anybody who comes in with a fever.

(READ COMPLETE ARTICLE)

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

9 Questions About this New Ebola Drug

      

cnn.com - by By Jacque Wilson and Danielle Dellorto - August 5, 2014

(CNN) -- Two American missionary workers infected with the deadly Ebola virus were given an experimental drug that seems to have saved their lives.

Dr. Kent Brantly was given the medication, ZMapp, shortly after telling his doctors he thought he would die, according to a source familiar with his case. Within an hour, doctors say his symptoms -- labored breathing and a widespread rash -- dramatically improved. Nancy Writebol, another missionary working with Samaritan's Purse, received two doses of the medication and has also shown significant improvement, sources say.

As there is no proven treatment and no vaccine for Ebola, this experimental drug is raising lots of questions.

(READ COMPLETE ARTICLE)

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Disease
howdy folks